Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Preguntas más frecuentes / Tipos de Cáncer / OncoLink Veterinario /
Ultima Vez Modificado: 21 de agosto del 2005
![]()
Dear OncoLink "Ask The Experts,"
Our 9-yr-old dog has been diagnosed with lymphoblastic leukemia. He is currently on 2 mg/day of Leukeran and 20 mg/day of prednisone.
His most recent CBC showed almost normal platelets and hematocrit of 22%.
His lymphocytes were originally 100,000, came down to 9,000 after 2 wks on leukeron, but have now gone back up (we don't have the exact numbers). Can he stay on these drugs indefinitely? What can we expect? Does this cancer go into remission? Is there anything else (within reason - we won't make the dog suffer) that can be done?
Lili Duda, VMD, Section Editor of the OncoLink Veterinary Oncology Menu, responds:
Chronic LYMPHOCYTIC leukemia (CLL) usually occurs in older dogs and is a condition in which mature (i.e., "normal"-looking) lymphocytes reproduce rapidly in the body (including the bone marrow). This results in very elevated circulating lymphocyte counts on CBC blood tests. CLL is often found "accidentally" when blood work is being performed for other reasons. The condition usually progresses slowly, and is often not treated until either the dog becomes symptomatic (with lethargy being the most common sign), or the circulating lymphocyte count is quite high. Dogs are typically treated with an oral maintenance chemotherapy protocol with drugs such as prednisone and chlorambucil (Leukeran), along with periodic monitoring of blood cells counts and physical examinations. Most dogs do ultimately progress over the course of months to years and develop involvement of lymph nodes, spleen, and liver. Occasionally, there will be progression to a LYMPHOBLASTIC crisis, in which the lymphocytes become increasingly immature, or "blastic", and the disease takes on a more aggressive course. It is not possible to predict how long your dog can remain on the maintenance medications before the disease progresses, but it could be some time.
LYMPHOBLASTIC leukemia (or lymphoblastic crisis) is comparable in many ways to stage V lymphoma in dogs. This is a condition in which there is a rapid production of immature lymphocytes, known as lymphoblasts, within the body. A stage V (five) lymphoma means that these cancerous cells have infiltrated the bone marrow and are present in the circulation. The cells are also typically found in lymph nodes throughout the body, along with the spleen and liver. Other sites, such as the gastrointestinal system, can also be involved. Lymphoma is typically treated with a combination chemotherapy protocol that involves both injectable drugs as well as oral medications. There is typically an "induction phase" where chemotherapy is more intensive, and then a maintenance phase that is used once patients are in remission. There are several prognostic factors (including stage and substage), and a variety of chemotherapy protocols. In general, about 80% of dogs go into a clinical remission, and in those dogs, the average survival is about 1 year. Please see the information posted elsewhere on OncoLink about lymphoma in dogs.
Dr. Rustgi discusses genomics and cancer and translating laboratory research into clinical practice. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

